Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System

NCT04861805 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 267

Last updated 2025-06-29

No results posted yet for this study

Summary

This is a prospective, single arm, multicenter study in an cohort of up to 267 patients (up to 100 Roll-ins and 167 patients implanted per protocol) symptomatic patients with severe aortic stenosis who will be followed up for up to 5 years.

Conditions

  • Symptomatic Aortic Stenosis

Interventions

DEVICE

Vienna Aortic Valve SE System

Vienna Aortic Valve SE system for TAVI.

Sponsors & Collaborators

  • Meditrial USA Inc.

    collaborator INDUSTRY
  • P+F Products + Features GmbH

    lead INDUSTRY

Principal Investigators

  • Alexandre Abizaid, MD · Instituto do Coração (InCor) de São Paulo

  • Carla Agatiello, MD · Hospital Italiano de Buenos Aires

  • Alejandro Alvarez Iorio, MD · Hospital Privado Sur (FUMEBA)

  • Ignacio J Amat-Santos, MD · University Clinical Hospital of Valladolid

  • Rimantas Benetis, MD · Lithuanian University of Health Sciences

  • Pedro Braga, MD · Unidade Local de Saúde de Gaia e Espinho

  • Juan Horacio A Briales, MD · Hospital Virgen de la Victoria

  • João Brito, MD · Hospital de Santa Cruz

  • Duarte Cacela, MD · Hospital Santa Marta

  • Adriano M Caixeta, MD · Escola Paulista de Medicina da UNIFESP

  • Praveen Chandra, MD · Medanta - The Medicity Hospital

  • Christian Dauvergne, MD · Hospital del Tórax de Santiago

  • Pedro C Ferreira, MD · Hospital Santa Maria

  • John Jose E, MD · Christian Medical College Hospital

  • Rony Mathew Kadavil, MD · Lisie Hospital

  • Gabriel Maluenda, MD · Hospital Clínico San Borja Arriarán

  • Cesar R Medeiros, MD · Instituto Nacional de Cardiologia

  • Oscar Mendiz, MD · Fundación Favaloro

  • Sanjay Mehrotra, MD · Narayana Health Hospital

  • Marcio J Montenegro Da Costa, MD · Instituto Estadual de Cardiologia Aloysio de Castro

  • Cesar Morís de La Tassa, MD · Hospital Universitario Central de Asturias

  • Luis Nombela, MD · Hospital San Carlos, Madrid

  • Juan Oteo, MD · Hospital Puerta De Hierro

  • Lino MD Patrício, MD · Hospital do Espírito Santo de Évora

  • Osvaldo Perez, MD · Hospital Las Higueras - Talcahuano

  • Ravinder Singh Rao, MD · RHL - Rajasthan Hospital

  • Ángel S Recalde, MD · Hospital Universitario Ramón y Cajal

  • Ander Regueiro, MD · Hospital Clinic of Barcelona

  • Lluis A Serra, MD · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

  • Dimytri Siqueira, MD · Instituto Dante Pazzanese de Cardiologia

  • Hakan Ucar, MD · İ.A.Ü. VM Medical Park Florya Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-03
Primary Completion
2025-10-31
Completion
2030-10-31

Countries

  • Argentina
  • Brazil
  • Chile
  • India
  • Lithuania
  • Portugal
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04861805 on ClinicalTrials.gov